Status:
COMPLETED
High Plasma Level of Long Pentraxin 3 is Associated With Insulin Resistance in Women With Polycystic Ovary Syndrome (PCOS)
Lead Sponsor:
Gulhane School of Medicine
Conditions:
PCOS
Eligibility:
FEMALE
18-40 years
Brief Summary
In the present study, serum pentraxin 3 level and its relationship with insulin resistance were determined in patients with Polycystic Ovary Syndrome (PCOS. It was found that PTX3 level is increased i...
Eligibility Criteria
Inclusion
- Absence of significant abnormalities on physical examination except hirsutism
- No lipid lowering, hypoglycemic, antihypertensive or hormone replacement therapy
- Normal thyroid function and prolactin level
- Absence of history or evidence of metabolic, cardiovascular, respiratory or hepatic disease
Exclusion
- Pregnant
- Possible ovarian tumors,
- Congenital adrenal hyperplasia or
- BMI greater than 35 kg/m2
Key Trial Info
Start Date :
May 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01463969
Start Date
May 1 2010
End Date
May 1 2011
Last Update
November 2 2011
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Gulhane School of Medicine Dep. of Endocrine and Metabolism
Ankara, Turkey (Türkiye), 06018
2
Gulhane School of Medicine Dep. of Endocrinology and Metabolism
Ankara, Turkey (Türkiye), 06018
3
Gulhane School of Medicine
Ankara, Turkey (Türkiye), 06018